GHS-R1a signaling drives anxiety-related behavior by shaping excitability of ventromedial hypothalamic neurons.

Zhang, Meng; Yang, Liu; Mi, Xue; Hu, Gonghui; Lu, Yingchang; Wang, Chen; Yang, Jie; Sun, Xiaomin et al. · Nat Commun · 2025

basic_science · Level V

Where this comes from

Abstract

The neural substrates of anxiety are poorly understood, which hinders treatment of anxiety disorders. Here we found, αCaMKII<sup>+</sup> neurons in the ventral medial hypothalamic nucleus (VMH) responded to stressors with increased activity in male mice, both under physiological conditions and after repeated restraint stress. Activation of VMH αCaMKII<sup>+</sup> neurons were necessary and sufficient to ameliorate stress-induced anxiety. The peripheral metabolic hormone ghrelin and receptor GHS-R1a play a complex role in emotion regulation; however, the mechanism is uncertain. A delayed increase in GHS-R1a expression in VMH αCaMKII<sup>+</sup> neurons coincided with the development of stress-induced enhancement of anxiety-related behavior. GHS-R1a expression in VMH αCaMKII<sup>+</sup> neurons promoted anxiety-related behavior, whereas GHS-R1a knockdown had the opposite effect. GHS-R1a upregulation inhibited the excitability of VMH αCaMKII<sup>+</sup> neurons. We conclude that GHSR1a signaling drives stress-induced anxiety by shaping the activity of VMH αCaMKII<sup>+</sup> neurons. GHS-R1a may be a therapeutic target for treating anxiety disorders such as post-traumatic stress disorder.

Medical subject headings